Transparent, promt
and comprehensive
- information straight to the point

News

01/10/12, Bayer HealthCare Pharmaceuticals Phase III Data of Bayer’s Regorafenib in Patients with Metastatic Colorectal Cancer to be Presented as Late Breaking Oral Presentation at 2012 ASCO-GI Congress Late breaking abstract (LBA #385) of Phase III CORRECT study results to be presented on January 21, 2012 more

01/09/12, Bayer HealthCare Pharmaceuticals Bayer HealthCare to Share Lab Space with Start-Up Companies Dedicated lab space-model at Bayer HealthCare U.S. Innovation Center to be called CoLaborator™ / Shared lab space will help promising life science companies get their start more

12/29/11, Bayer HealthCare Pharmaceuticals Bayer’s Xarelto® (Rivaroxaban) Submitted for U.S. Marketing Authorisation to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome more

In Focus

11/15/2011
9th International Dialogue on Population and Sustainable Development “Education Matters: Empowering Young People to Make Healthier Choices”

At the time when the 7 billionth human war born, the 9th International Dialogue on Population and Sustainable Development took place in Berlin. Politicians, represe... more